An interventional cardiac device, mainly used for
monitoring, treating, or improving heart function, is a medical device
implanted into the heart through catheter technology. They are widely used in
the cardiovascular field and are one of the important means of modern heart
disease treatment.
Introduction to Main Product Types
|
Cardiac Pacemaker
|
Used to treat bradycardia by stimulating the
heart with electrical pulses to beat at an appropriate speed.
|
|
Implantable Cardioverter Defibrillator (ICD)
|
Used to treat malignant arrhythmias such as
ventricular tachycardia and ventricular fibrillation, it can automatically
defibrillate when abnormal heart rhythm is detected.
|
|
Cardiac Resynchronization Therapy (CRT)
|
Used to treat heart failure and cardiac
asynchrony, by coordinating the contraction of the left and right ventricles
to improve the efficiency of cardiac pumping.
|
|
Heart Valve Replacement Device
|
For the treatment of heart valve diseases, such
as aortic valve stenosis or reflux, artificial valves can be implanted
through catheter technology.
|
|
Cardiac Assist Device
|
Such as left ventricular assist devices (LVAD)
and right ventricular assist devices (RVAD), used to support heart function,
awaiting heart transplantation, or as a long-term treatment option.
|
Source:
www.globalmarketmonitor.com
Analysis of Market Driving Factors
The interventional cardiac device market in South Africa is currently in a phase of rapid growth. This is mainly due to several key factors:
The aging trend of the population in South Africa is increasingly obvious, and the incidence rate and mortality of cardiovascular diseases are also increasing year by year, which directly promotes the demand for cardiovascular intervention.
Interventional therapy has advantages over traditional surgical procedures such as minimal trauma, fast recovery, and good results, making it increasingly favored by patients and doctors.
With the advancement of technology, the technological innovation and product updates of cardiovascular intervention devices are also driving the development of the market, such as the emergence of new intervention devices such as bioabsorbable stents and transcatheter heart valve replacement, providing patients with more treatment options.
Overview of Market Development and Analysis of Competitive Landscape
According to our research data, the market size of interventional cardiac devices in South Africa was $52.95 million in 2023 and is expected to increase to $59.29 million by 2025.
From the perspective of market competition, the concentration of the interventional cardiac device market in South Africa is relatively low. According to our data, the total output value of interventional cardiac devices by the top 3 companies in 2023 was $15.13 million, with a total share of 28.57%. The top 3 companies were Abbott Laboratories, Medtronic, and Boston Scientific. In 2023, these three companies accounted for 11.83%, 8.60%, and 8.14% of the interventional cardiac device production value in the South African market, respectively.
South Africa Interventional Cardiac Device Market Size Forecast and Competitive Landscape Analysis
Source: www.globalmarketmonitor.com
Chinese